Overview

• Specialty materials firm's Q4 net sales slightly missed analyst expectations

• Q4 adjusted EBITDA decreased 12%, driven by lower volumes in key segments

• Company completed sale of North Charleston refinery assets

Outlook

• Ingevity expects 2026 net sales between $1.1 bln and $1.2 bln

• Company projects 2026 adjusted EBITDA between $380 mln and $400 mln

• Ingevity anticipates 2026 adjusted EPS between $4.80 and $5.20

Result Drivers

• TARIFF IMPACTS - Co said indirect tariff impacts weighed on demand in Advanced Polymer Technologies, affecting sales

• SUPPLY CHAIN DISRUPTIONS - Performance Materials sales were affected by supply chain disruptions in the auto industry, leading to lower volumes

• PORTFOLIO OPTIMIZATION - Co completed sale of North Charleston refinery assets and is exploring strategic alternatives for certain segments

Company press release: ID:nBw3Jg6Kma

Key Details

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the diversified chemicals peer group is "buy"

• Wall Street's median 12-month price target for Ingevity Corp is $70.50, about 0.9% below its February 24 closing price of $71.12

• The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 11 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)